NADOLOL AND BENDROFLUMETHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Nadolol And Bendroflumethiazide patents expire, and when can generic versions of Nadolol And Bendroflumethiazide launch?
Nadolol And Bendroflumethiazide is a drug marketed by Impax Labs and Natco Pharma and is included in two NDAs.
The generic ingredient in NADOLOL AND BENDROFLUMETHIAZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NADOLOL AND BENDROFLUMETHIAZIDE?
- What are the global sales for NADOLOL AND BENDROFLUMETHIAZIDE?
- What is Average Wholesale Price for NADOLOL AND BENDROFLUMETHIAZIDE?
Summary for NADOLOL AND BENDROFLUMETHIAZIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Patent Applications: | 28 |
| DailyMed Link: | NADOLOL AND BENDROFLUMETHIAZIDE at DailyMed |
Recent Clinical Trials for NADOLOL AND BENDROFLUMETHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mylan Pharmaceuticals | Phase 1 |
US Patents and Regulatory Information for NADOLOL AND BENDROFLUMETHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-001 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 078688-002 | Feb 15, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-002 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 078688-001 | Feb 15, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
